NORDIMET

22,5MG INJ SOL 4(4X1)X0,9ML PEP

Maximum ex-factory price/Ex-factory price ? 1817,96 CZK
Legal basis of maximum ex-factory price/ex-factory price ? Maximum ex-factory price set by the law.

Informace o základní úhradě

Core reimbursement from health insurance ? 1628,96 CZK
Maximum reimbursement from health insurance ? 2352,58 CZK
Legal basis of reimbursement from health insurance ? Reimbursement set by the law.
Indication restriction of reimbursement ? Léčba je hrazena v indikaci těžká aktivní revmatoidní artritida při nedostatečném účinku maximální tolerované dávky perorální formy methotrexátu či intoleranci perorální formy methotrexátu. Dále je léčba hrazena v indikacích juvenilní idiopatická artritida a psoriatická artritida, je-li indikována léčba pomocí antirevmatik modifikujících průběh onemocnění (DMARD).
Prescribing doctor's specialisation ? Rheumatology, pediatric rheumatology
Dermatovenerology, children's dermatovenerology, corrective dermatology
Reporting limit ? L: Product subject to prescription restriction may be prescribed for reimbursement by a health insurer only by a doctor with specialist capacity, stating the professional field in the prescription restriction, who has concluded an agreement on the provision of the relevant health service with the health insurer in respect of the specialist capacity, or another doctor under written authority of the Specialist Doctor.
Rough price for the final consumer ? 2431,01 CZK
Rough payment for the final consumer (for 1 prescribed package dispensed) ? 78.43 CZK
Eligible extra payment ?
Eligible extra payment for individuals aged 65 and older ?
Medicinal products reimbursed from health insurance contain the amount of the maximum manufacturer´s price or the producer´s notified price for products which are not subjected to the regulation of the maximum manufacturer´s price, the amount of reimbursement from health insurance and the estimated price for the end consumer (pharmacy price).

Back to list